Recent studies on tumor-derived EVs show they can modulate gene expression in endothelial cells, promoting VEGF, VWF, VEGFR2, CXCL5, and CCR1 expression and enhancing endothelial cell proliferation and migration [43,94,95]. The gene discussed is CCR1; the disease is neoplasm.